has been cited by the following article(s):
|
[1]
|
Cholesterol Functionalized Nanoparticles Are Effective against Helicobacter pylori, the Gastric Bug: A Proof‐of‐Concept Study
Advanced Healthcare Materials,
2025
DOI:10.1002/adhm.202404065
|
|
|
|
|
[2]
|
Helicobacter pylori components increase the severity of metabolic syndrome and its hepatic manifestations induced by a high fat diet
Scientific Reports,
2024
DOI:10.1038/s41598-024-56308-7
|
|
|
|
|
[3]
|
Helicobacter pylori metabolites exacerbate gastritis through C-type lectin receptors
Journal of Experimental Medicine,
2021
DOI:10.1084/jem.20200815
|
|
|
|
|
[4]
|
Cholesterol glucosylation–based survival strategy in Helicobacter pylori
Helicobacter,
2021
DOI:10.1111/hel.12777
|
|
|
|
|
[5]
|
Helicobacter pylori metabolites exacerbate gastritis through C-type lectin receptors
Journal of Experimental Medicine,
2021
DOI:10.1084/jem.20200815
|
|
|
|
|
[6]
|
Cholesterol glucosylation–based survival strategy in
Helicobacter pylori
Helicobacter,
2020
DOI:10.1111/hel.12777
|
|
|
|
|
[7]
|
A Comprehensive Review on Oxysterols and Related Diseases
Current Medicinal Chemistry,
2020
DOI:10.2174/0929867327666200316142659
|
|
|
|
|
[8]
|
Unique responses of Helicobacter pylori to exogenous hydrophobic compounds
Chemistry and Physics of Lipids,
2020
DOI:10.1016/j.chemphyslip.2020.104908
|
|
|
|
|
[9]
|
Gastritis - New Approaches and Treatments [Working Title]
2019
DOI:10.5772/intechopen.86165
|
|
|
|